000 | 01345 a2200361 4500 | ||
---|---|---|---|
005 | 20250515150620.0 | ||
264 | 0 | _c20081231 | |
008 | 200812s 0 0 ger d | ||
022 | _a1438-3276 | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_a[Individualized therapy with fosamprenavir/r. A PI suitable in liver problems]. _h[electronic resource] |
260 |
_bMMW Fortschritte der Medizin _cApr 2008 |
||
300 |
_a60-1 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFurans |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLiver Function Tests |
650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
650 | 0 | 4 |
_aRitonavir _xadministration & dosage |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 | _aViral Load |
773 | 0 |
_tMMW Fortschritte der Medizin _gvol. 150 Spec No 1 _gp. 60-1 |
|
999 |
_c18487605 _d18487605 |